Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belatacept versus calcineurin inhibitor biomarkers study in kidney transplant recipients
NL-OMON42067Active, not recruiting
- Sponsor
- Nierziekten
- Start
- Mar 2015
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of belatacept in kidney transplant (2 arms), sponsored by Nierziekten. Primary endpoints: Differences in circulating endothelial cells, Differences in circulating monocytes and 4 more. Started Mar 2015; status: active, not recruiting.
02
Drugs
belatacept
03
Conditions
kidney transplant
Beyond the preview
Go deeper on NL-OMON42067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42067.